Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.65 |
| ▸ | HPGD | P15428 | 2/20 | 0.65 |
| ▸ | CISD1 | Q9NZ45 | 1/20 | 0.65 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.65 |
| ▸ | SLC16A1 | P53985 | 1/20 | 0.65 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.65 |
| ▸ | EGFR | P00533 | 1/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.62 |
| ▸ | APEX1 | P27695 | 1/20 | 0.62 |
| ▸ | BLM | P54132 | 1/20 | 0.62 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.62 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL782092 | 1.00 | ALDH1A1 (0.65) | ALDH1A1KDM4ECYP3A4HPGDCISD1 | |
| SCHEMBL782091 | 1.00 | ALDH1A1 (0.65) | ALDH1A1KDM4ECYP3A4HPGDCISD1 | |
| SCHEMBL21625778 | 0.95 | ALDH1A1 (0.59) | ALDH1A1KDM4ECYP3A4HPGDCISD1 | |
| SCHEMBL21637629 | 0.95 | ALDH1A1 (0.59) | ALDH1A1KDM4ECYP3A4HPGDCISD1 | |
| SCHEMBL21625782 | 0.95 | ALDH1A1 (0.59) | ALDH1A1KDM4ECYP3A4HPGDCISD1 | |
| SCHEMBL7008415 | 0.88 | SLC16A3 (0.57) | ALDH1A1KDM4ECYP3A4HPGDCISD1 | |
| SCHEMBL28335121 | 0.88 | SLC16A3 (0.67) | ALDH1A1KDM4ECYP3A4HPGDCISD1 | |
| SCHEMBL17112792 | 0.88 | KDM4E (0.64) | ALDH1A1KDM4ECYP3A4HPGDCISD1 | |
| SCHEMBL17112791 | 0.88 | KDM4E (0.64) | ALDH1A1KDM4ECYP3A4HPGDCISD1 | |
| SCHEMBL13060202 | 0.88 | MAPT (0.72) | ALDH1A1KDM4ECYP3A4HPGDCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11802106-B2 | Cathode buffer layer material and organic or organic/inorganic hybrid photoelectric device comprising same | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2023-10-31 | — | — | US | claimed |
| US-20210198188-A1 | NOVEL CATHODE BUFFER LAYER MATERIAL AND ORGANIC OR ORGANIC/INORGANIC HYBRID PHOTOELECTRIC DEVICE COMPRISING SAME | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2021-07-01 | — | — | US | claimed |
| EP-1594880-B1 | PHOTOPROTECTIVE COMPOSITIONS BASED ON METHYLTRIALKYLSILANES CONTAINING A CINNAMATE, CINNAMAMIDE, BENZALMALONAMIDE OR BENZALMALONATE FUNCTION | OREAL (FR) | 2008-03-19 | — | — | EP | claimed |
| EP-4067367-B1 | OLEANANE CINNAMAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF | LUNAN PHARMACEUTICAL GROUP CORP (CN) | 2025-05-28 | — | — | EP | disclosed |
| US-11802106-B2 | Cathode buffer layer material and organic or organic/inorganic hybrid photoelectric device comprising same | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2023-10-31 | — | — | US | disclosed |
| US-20230023332-A1 | OLEAN-PHENYLACRYLAMIDE DERIVATIVE, METHOD FOR PREPARING SAME, AND USE THEREOF | LUNAN PHARMACEUTICAL GROUP CORPORATION (CN) | 2023-01-26 | — | — | US | disclosed |
| EP-4067367-A1 | OLEANANE CINNAMAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF | Lunan Pharmaceutical Group Corporation (CN) | 2022-10-05 | — | — | EP | disclosed |
| US-20210198188-A1 | NOVEL CATHODE BUFFER LAYER MATERIAL AND ORGANIC OR ORGANIC/INORGANIC HYBRID PHOTOELECTRIC DEVICE COMPRISING SAME | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2021-07-01 | — | — | US | disclosed |
| WO-2021104391-A1 | OLEANANE CINNAMAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF | 鲁南制药集团股份有限公司 | 2021-06-03 | — | — | WO | disclosed |
| EP-3515902-A1 | 6-MEMBERED CYCLIC AMINES OR LACTAMES SUBSTITUTED WITH UREA AND PHENYL | Grünenthal GmbH (DE) | 2019-07-31 | — | — | EP | disclosed |
| US-10265310-B2 | 6-membered cyclic amines or lactames substituted with urea and phenyl | Grünenthal GmbH (DE) | 2019-04-23 | — | — | US | disclosed |
| US-20040074012-A1 | Method for providing textile material with uv protection | BASF AKTIENGESELLSCHAFT (DE) | 2004-04-22 | — | — | US | disclosed |
| EP-1383952-A2 | METHOD FOR PROVIDING TEXTILE MATERIAL WITH UV PROTECTION | BASF AKTIENGESELLSCHAFT (DE) | 2004-01-28 | — | — | EP | disclosed |
| US-20030127633-A1 | Uv absorbing mixture with textile fiber affinity | BASF AKTIENGESELLSCHAFT (DE) | 2003-07-10 | — | — | US | disclosed |
| EP-1267820-A2 | UV-ABSORBING MIXTURE WITH TEXTILE FIBRE AFFINITY | BASF AKTIENGESELLSCHAFT (DE) | 2003-01-02 | — | — | EP | disclosed |
| WO-2002063091-A2 | METHOD FOR PROVIDING TEXTILE MATERIAL WITH UV PROTECTION | BASF AKTIENGESELLSCHAFT (DE) | 2002-08-15 | — | — | WO | disclosed |
| WO-2001072935-A2 | UV-ABSORBING MIXTURE WITH TEXTILE FIBRE AFFINITY | BASF AKTIENGESELLSCHAFT (DE) | 2001-10-04 | — | — | WO | disclosed |
| EP-1126833-A2 | OXADIAZOLE, THIADIAZOLE AND TRIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF | TREGA BIOSCIENCES, INC. (US) | 2001-08-29 | — | — | EP | disclosed |
| EP-0901512-B1 | DETERGENT COMPOSITION | UNILEVER PLC (GB) | 2000-06-21 | — | — | EP | disclosed |
| WO-2000025768-A1 | OXADIAZOLE, THIADIAZOLE AND TRIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF | TREGA BIOSCIENCES, INC. (US) | 2000-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230023332-A1 | OLEAN-PHENYLACRYLAMIDE DERIVATIVE, METHOD FOR PREPARING SAME, AND USE THEREOF | PAOX, ALOX12, PNMT | ALDH1A1 418/4885KDM4E 991/4885CYP3A4 163/4885 |
| US-11802106-B2 | Cathode buffer layer material and organic or organic/inorganic hybrid photoelectric device comprising same | DCX, CDH1, CACNA2D3 | ALDH1A1 3065/4885KDM4E 1369/4885CYP3A4 3086/4885 |
| US-20210198188-A1 | NOVEL CATHODE BUFFER LAYER MATERIAL AND ORGANIC OR ORGANIC/INORGANIC HYBRID PHOTOELECTRIC DEVICE COMPRISING SAME | DCX, HCN3, CDH1 | ALDH1A1 3167/4885KDM4E 1555/4885CYP3A4 3511/4885 |
| US-10265310-B2 | 6-membered cyclic amines or lactames substituted with urea and phenyl | FPR2, FPR1, FPR3 | ALDH1A1 3156/4885KDM4E 4525/4885CYP3A4 2271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.